Flow-Diverter Stenting of Intracavernous Internal Carotid Artery Mycotic Aneurysm
This is the first reported case in which a mycotic aneurysm refractory to the first medical treatment was treated with a Pipeline embolization device (PED), and the first case of a mycotic aneurysm from Brucella treated by endovascular therapy. A 35-year-old man presented with left eye pain and ptos...
        Saved in:
      
    
          | Published in | Journal of Stroke and Cerebrovascular Diseases Vol. 28; no. 7; pp. e81 - e82 | 
|---|---|
| Main Authors | , , | 
| Format | Journal Article | 
| Language | English | 
| Published | 
        United States
          Elsevier Inc
    
        01.07.2019
     Elsevier BV  | 
| Subjects | |
| Online Access | Get full text | 
| ISSN | 1052-3057 1532-8511 1532-8511  | 
| DOI | 10.1016/j.jstrokecerebrovasdis.2019.04.026 | 
Cover
| Summary: | This is the first reported case in which a mycotic aneurysm refractory to the first medical treatment was treated with a Pipeline embolization device (PED), and the first case of a mycotic aneurysm from Brucella treated by endovascular therapy. A 35-year-old man presented with left eye pain and ptosis, and fever for 2 weeks. Before symptom onset, he visited Vietnam where he developed a flu-like illness; however, antibiotics were ineffective. We suspected Brucella as the most likely infectious etiology for the patient's intracavernous aneurysm. Since the aneurysm did not reduce in size following 2 weeks of antibiotic therapy, we placed a PED in the left internal carotid artery. Follow-up angiogram 4 months later showed no residual aneurysm, and cranial nerve palsies had completely resolved. From the results of this case, it appears that flow diverter stenting may be a safe and effective treatment of mycotic aneurysms of the cavernous segment of ICA. | 
|---|---|
| Bibliography: | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Feature-4 content type line 23 ObjectType-Report-1 ObjectType-Article-3  | 
| ISSN: | 1052-3057 1532-8511 1532-8511  | 
| DOI: | 10.1016/j.jstrokecerebrovasdis.2019.04.026 |